#HealthcareInnovation #Biopharmaceuticals #GlobalMarkets
seekingalpha.com
Hello, Goodbye: Europe Loses Ground As China Becomes Powerhouse Of Innovation
However, in recent years, China has surpassed Europe in the number of new global drug approvals, and it is edging closer to the US.
#Pelthos #Xeglyze #Biopharmaceuticals
www.benzinga.com
Pelthos Therapeutics Acquires Xeglyze® (abametapir) Topical Treatment for Head Lice - Pelthos Therapeutics (AMEX:PTHS)
Acquisition adds complementary asset to the Pelthos commercial portfolioXeglyze is a novel, FDA-approved prescription medication indicated for the topical treatment of head lice infestation in patients 6 months of age and older
DURHAM, N.
